AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
For the first time on The Red Light Report, I had the pleasure of meeting and speaking with a photobiomodulation researcher and expert. And Dr. Praveen Arany is not just an average, ordinary researcher by any stretch of the imagination — this guy has quite the reputation in the photobiomodulation world and beyond. We cover an array of red light therapy topics that will surely give you a clearer idea of what red light therapy is, how to best utilize it and what has Dr. Arany most excited about the future of photobiomodulation.
He has over 100 scientific publications with several well cited papers to his credit. A complete list of his publications on Pubmed is available here. He is a recipient of numerous awards and has been invited to speak in various national and international forums, reviews for over 50 scientific journals, serves on 9 journal editorial boards. Besides his academic interests in clinical translational research, Dr. Arany has co-founded three biotechnology companies to translate his lab research into real-world, practical solutions to improve clinical care.vThe overall scientific focus of the Arany lab is to identify key biological regulatory components that can be used in clinical studies to control biological outcomes. His research is predominantly focused on the molecular mechanisms and clinical translation of low dose light treatments, termed Photobiomodulation Therapy, to alleviate pain or inflammation and promote tissue healing and regeneration.
Dr. Mike Belkowski & Dr. Praveen Arany discuss the following:
-
Watch this episode on YouTube
-
Dr. Praveen Arany's Website & Social: Instagram - @praveenarany Buffalo University Website LinkedIn - Praveen Arany - Invest in BioLight:To learn more about red light therapy and shop for the highest-quality red light therapy products, visit www.biolight.shop
-
Stay up-to-date on social media: